Department of Neurosurgery, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Health Technol Assess. 2023 Oct;27(21):1-228. doi: 10.3310/OTOH7720.
Posterior cervical foraminotomy and anterior cervical discectomy are routinely used operations to treat cervical brachialgia, although definitive evidence supporting superiority of either is lacking.
The primary objective was to investigate whether or not posterior cervical foraminotomy is superior to anterior cervical discectomy in improving clinical outcome.
This was a Phase III, unblinded, prospective, United Kingdom multicentre, parallel-group, individually randomised controlled superiority trial comparing posterior cervical foraminotomy with anterior cervical discectomy. A rapid qualitative study was conducted during the close-down phase, involving remote semistructured interviews with trial participants and health-care professionals.
National Health Service trusts.
Patients with symptomatic unilateral cervical brachialgia for at least 6 weeks.
Participants were randomised to receive posterior cervical foraminotomy or anterior cervical discectomy. Allocation was not blinded to participants, medical staff or trial staff. Health-care use from providing the initial surgical intervention to hospital discharge was measured and valued using national cost data.
The primary outcome measure was clinical outcome, as measured by patient-reported Neck Disability Index score 52 weeks post operation. Secondary outcome measures included complications, reoperations and restricted American Spinal Injury Association score over 6 weeks post operation, and patient-reported Eating Assessment Tool-10 items, Glasgow-Edinburgh Throat Scale, Voice Handicap Index-10 items, PainDETECT and Numerical Rating Scales for neck and upper-limb pain over 52 weeks post operation.
The target recruitment was 252 participants. Owing to slow accrual, the trial closed after randomising 23 participants from 11 hospitals. The qualitative substudy found that there was support and enthusiasm for the posterior cervical FORaminotomy Versus Anterior cervical Discectomy in the treatment of cervical brachialgia trial and randomised clinical trials in this area. However, clinical equipoise appears to have been an issue for sites and individual surgeons. Randomisation on the day of surgery and processes for screening and approaching participants were also crucial factors in some centres. The median Neck Disability Index scores at baseline (pre surgery) and at 52 weeks was 44.0 (interquartile range 36.0-62.0 weeks) and 25.3 weeks (interquartile range 20.0-42.0 weeks), respectively, in the posterior cervical foraminotomy group ( = 14), and 35.6 weeks (interquartile range 34.0-44.0 weeks) and 45.0 weeks (interquartile range 20.0-57.0 weeks), respectively, in the anterior cervical discectomy group ( = 9). Scores appeared to reduce (i.e. improve) in the posterior cervical foraminotomy group, but not in the anterior cervical discectomy group. The median Eating Assessment Tool-10 items score for swallowing was higher (worse) after anterior cervical discectomy (13.5) than after posterior cervical foraminotomy (0) on day 1, but not at other time points, whereas the median Glasgow-Edinburgh Throat Scale score for globus was higher (worse) after anterior cervical discectomy (15, 7, 6, 6, 2, 2.5) than after posterior cervical foraminotomy (3, 0, 0, 0.5, 0, 0) at all postoperative time points. Five postoperative complications occurred within 6 weeks of surgery, all after anterior cervical discectomy. Neck pain was more severe on day 1 following posterior cervical foraminotomy (Numerical Rating Scale - Neck Pain score 8.5) than at the same time point after anterior cervical discectomy (Numerical Rating Scale - Neck Pain score 7.0). The median health-care costs of providing initial surgical intervention were £2610 for posterior cervical foraminotomy and £4411 for anterior cervical discectomy.
The data suggest that posterior cervical foraminotomy is associated with better outcomes, fewer complications and lower costs, but the trial recruited slowly and closed early. Consequently, the trial is underpowered and definitive conclusions cannot be drawn. Recruitment was impaired by lack of individual equipoise and by concern about randomising on the day of surgery. A large prospective multicentre trial comparing anterior cervical discectomy and posterior cervical foraminotomy in the treatment of cervical brachialgia is still required.
This trial is registered as ISRCTN10133661.
This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full in ; Vol. 27, No. 21. See the NIHR Journals Library website for further project information.
后路颈椎椎间孔切开术和前路颈椎间盘切除术是常规用于治疗颈臂痛的手术,但缺乏支持任何一种手术方法具有优越性的确凿证据。
主要目的是调查后路颈椎椎间孔切开术是否优于前路颈椎间盘切除术,以改善临床结果。
这是一项 III 期、非盲、前瞻性、英国多中心、平行组、个体随机对照优效性试验,比较后路颈椎椎间孔切开术与前路颈椎间盘切除术。在关闭阶段进行了一项快速定性研究,对试验参与者和医疗保健专业人员进行了远程半结构式访谈。
国民保健制度信托基金。
患有单侧颈臂痛至少 6 周的症状性患者。
参与者被随机分配接受后路颈椎椎间孔切开术或前路颈椎间盘切除术。参与者、医务人员和试验人员均未对分配情况进行盲法。使用国家成本数据测量并评估从提供初始手术干预到出院的医疗保健使用情况。
主要结局测量指标是术后 52 周时患者报告的颈部残疾指数评分,作为临床结局。次要结局测量指标包括术后 6 周内的并发症、再次手术和受限的美国脊髓损伤协会评分,以及术后 52 周内的患者报告的吞咽评估工具-10 项、格拉斯哥-爱丁堡咽喉量表、嗓音障碍指数-10 项、疼痛 DETECT 和颈部和上肢疼痛的数字评分量表。
目标招募人数为 252 人。由于入组速度较慢,该试验在从 11 家医院随机分配 23 名参与者后关闭。定性子研究发现,后路颈椎椎间孔切开术与前路颈椎间盘切除术治疗颈臂痛试验以及该领域的随机临床试验受到支持和欢迎。然而,对于各中心和个别外科医生来说,临床平衡似乎是一个问题。在一些中心,手术当天的随机化和筛选及接触参与者的过程也是关键因素。后路颈椎椎间孔切开术组( = 14)的基线(术前)和 52 周时的中位数颈部残疾指数评分分别为 44.0(四分位距 36.0-62.0 周)和 25.3 周(四分位距 20.0-42.0 周),前路颈椎间盘切除术组( = 9)的中位数颈部残疾指数评分分别为 35.6 周(四分位距 34.0-44.0 周)和 45.0 周(四分位距 20.0-57.0 周)。后路颈椎椎间孔切开术组的评分似乎有所降低(即改善),但前路颈椎间盘切除术组的评分没有改善。后路颈椎椎间孔切开术后第 1 天吞咽评估工具-10 项评分的中位数为 13.5(更差),高于前路颈椎间盘切除术后的 0(更佳),但在其他时间点则不然,而前路颈椎间盘切除术后第 1 天的格拉斯哥-爱丁堡咽喉量表评分的中位数为 15、7、6、6、2、2.5,后路颈椎椎间孔切开术后的中位数为 3、0、0、0.5、0、0,均高于后路颈椎椎间孔切开术。术后 6 周内发生 5 例术后并发症,均发生在前路颈椎间盘切除术组。后路颈椎椎间孔切开术后第 1 天的颈部疼痛评分(颈部疼痛数字评分量表)高于前路颈椎间盘切除术组(7.0)。后路颈椎椎间孔切开术组提供初始手术干预的中位医疗保健成本为 2610 英镑,前路颈椎间盘切除术组为 4411 英镑。
数据表明后路颈椎椎间孔切开术与更好的结果、更少的并发症和更低的成本相关,但该试验入组速度较慢,提前关闭。因此,该试验的效能不足,无法得出明确的结论。入组受到缺乏个体平衡和对手术当天进行随机化的担忧的影响。仍需要一项比较前路颈椎间盘切除术和后路颈椎椎间孔切开术治疗颈臂痛的大型前瞻性多中心试验。
本试验已在 ISRCTN 注册,注册号为 ISRCTN82466124。
本项目由英国国家卫生与保健优化研究所(NIHR)卫生技术评估计划资助,全文将在 ; Vol. 27, No. 21 中发表。有关该项目的更多信息,请访问 NIHR 期刊库网站。